Epilepsy is a common problem in dogs, and management of this chronic disorder requires a substantial commitment on the part of the pet owner. The aim of this study was to evaluate the impact of epilepsy in dogs on their owners, utilizing an online survey tool. A questionnaire was developed to explore a variety of factors, including seizure history, treatment, outcome, quality of life, costs associated with therapy, and sources of support. A total of 225 responses were obtained.
for distribution by the North Carolina State University Institutional Review Board.
Survey forms were developed using traditional survey design techniques and were adapted for online use. Owners were asked to respond to 59 questions that included a combination of short answer, multiple choice, and Likert-scale responses. The range of questions included general demographic data, seizure information, and medication history as well as questions designed to assess QOL (Appendix 1). The survey program was such that it was not possible to force an answer for every question; consequently, respondents could successfully submit the survey with questions left unanswered. The survey instrument was available online from July 2011 through August 2012.
Statistical Analysis
All statistical analyses were performed using statistical analysis software b . Summary statistics (means and standard errors, ranges, and frequencies and proportions) were calculated for responses to all questions. Chi-squared tests were used to test for an association between presence of specific side effects and the use of particular drugs. Quality of life before and after the onset of seizures was compared using a paired t-test. Other QOL comparisons were performed using analysis of variance, with least-squares means and posthoc testing used to determine the size and direction of any statistically significant (p , .05) effect. Tukey's adjustment for multiple comparisons was used for all posthoc testing. 
Results

Demographics
Environmental Factors
One hundred sixty-seven survey respondents reported that they 
Treatment
Data on number of daily antiepileptic drugs administered to dogs is summarized in Figure 1 . The most common anticonvulsant being administered was phenobarbital, which was given to 86% of dogs, followed by bromide (52%), levetiracetam (29%), zonisamide (22%), and gabapentin (6% Table 1 .
Sources of Support
Owners were asked if they received support from veterinary professionals in the management of their dog's long-term care.
Eighty percent (181) reported receiving veterinary support, 11%
(24) responded that they did not receive ongoing veterinary support, and 9% were not sure. Sources of veterinary support included the veterinarian (reported by 89% of owners), online educational materials (26%), veterinary technician (24%), printed educational materials (10%), and client-to-client interactions (8%).
One hundred fifty-four owners also reported subscribing to online support groups for owners of pets with epilepsy, such as Epil-K9, Epi Guardian Angels, and Toby's Foundation. 
Quality of Life
Discussion
The primary objective of this study was to provide insight into Australian shepherds and border collies have been reported to have a severe form of epilepsy, and it is possible that owners of these dogs may consequently be more willing to complete a survey related to epilepsy. 8, 9 In addition, these breed groups may already have a higher level of owner-to-owner interaction related to epilepsy and may have publicized the study to a greater extent compared to other breed groups.
Forty-five percent of respondents reported good control of their dog's seizures, with an average seizure frequency of less than 1 a mo. This included 12% of dogs that were reported to be free of seizures in the 6 mo prior to survey completion. Although remission from seizures is typically reserved for dogs that have been seizure free for a year or longer, this number is comparable to the 15% remission rate previously reported for dogs. 5 Survey respondents reported that 62.5% of dogs either died or were euthanized due to their epilepsy. Previous studies have reported that 50-74% of all deaths with idiopathic epilepsy can be clinical study with dogs that were being administered phenobarbital for chronic seizures demonstrated positive ratings similar to those in the present study. 5 Owners in this prior study reported a willingness to maintain their dog on long-term therapy for epilepsy, with 95% disagreeing that their dog was leading a poor QOL since beginning treatment. Furthermore, all owners reported that the work necessary to maintain their epileptic pet was not a burden or detriment to their own QOL. However, another prospective, longitudinal study of 63 dogs diagnosed with epilepsy that were followed up until death, euthanasia, or a maximum of 12 yr described 60% of owners reporting that having a dog with epilepsy had a negative influence on their daily life. 4 These differing results may be due to the broader study population and a longer, defined follow-up period utilized in the latter study. Additional research is needed in this area to better characterize the QOL issues that are important in the long-term management of dogs with epilepsy.
A survey instrument was recently developed and validated for owners of dogs with epilepsy that aims to provide disease-specific questions for the pet owner relating to physical, social, and neurobehavioral aspects of QOL for both the pet and caregiver. Thank you for completing this study.
